EmStop, Inc., a cardiovascular medical device company, announced the initiation of the CAPTURE-2 Investigational Device Exemption (IDE) clinical trial in support of the company's mission to develop ...

EmStop has initiated the CAPTURE-2 IDE clinical trial to support the firm’s mission to develop an embolic protection system ...

Alzheimer’s doesn’t begin with memory loss. It starts decades earlier. New research reveals that a simple trace mineral may ...

What if the very structures we thought were destroying the brain are actually trying to save it? A new study reveals that ...

For years, researchers have been building an ever-longer list of dementia risk factors: poor diet, lack of exercise, social isolation, air pollution, untreated hearing loss, diabetes, high blood ...

An eviction in Lagos leaves 32 children with cerebral palsy and autism homeless, displacing them from their therapy center ...

A new study led by researchers at the University of California San Diego School of Medicine suggests that an experimental ...

Consumer neurotechnology is crossing an important threshold in 2026. Devices that read brain and muscle signals, in some cases acting on them in ...

Summary: A neuroimmunology study uncovered the cellular mechanism decoding why exercise improves neurological symptoms in ...

ZHUBEI, May 26, 2026 /PRNewswire/ -- Precision and minimally invasive are more than technical goals—they are a pledge to uphold patient dignity. In the high-stakes realm of neurosurgery, where the ...